Back to Search Start Over

Dbl family RhoGEFs in cancer: different roles and targeting strategies.

Authors :
Chen XY
Cheng AY
Wang ZY
Jin JM
Lin JY
Wang B
Guan YY
Zhang H
Jiang YX
Luan X
Zhang LJ
Source :
Biochemical pharmacology [Biochem Pharmacol] 2024 May; Vol. 223, pp. 116141. Date of Electronic Publication: 2024 Mar 16.
Publication Year :
2024

Abstract

Small Ras homologous guanosine triphosphatase (Rho GTPase) family proteins are highly associated with tumorigenesis and development. As intrinsic exchange activity regulators of Rho GTPases, Rho guanine nucleotide exchange factors (RhoGEFs) have been demonstrated to be closely involved in tumor development and received increasing attention. They mainly contain two families: the diffuse B-cell lymphoma (Dbl) family and the dedicator of cytokinesis (Dock) family. More and more emphasis has been paid to the Dbl family members for their abnormally high expression in various cancers and their correlation to poor prognosis. In this review, the common and distinctive structures of Dbl family members are discussed, and their roles in cancer are summarized with a focus on Ect2, Tiam1/2, P-Rex1/2, Vav1/2/3, Trio, KALRN, and LARG. Significantly, the strategies targeting Dbl family RhoGEFs are highlighted as novel therapeutic opportunities for cancer.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1873-2968
Volume :
223
Database :
MEDLINE
Journal :
Biochemical pharmacology
Publication Type :
Academic Journal
Accession number :
38499108
Full Text :
https://doi.org/10.1016/j.bcp.2024.116141